Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NLEA "significant scientific agreement" definition addressed in Keystone report -- Yetley.

This article was originally published in The Tan Sheet

Executive Summary

NLEA HEALTH CLAIM "SIGNIFICANT SCIENTIFIC AGREEMENT" DEFINITION will be addressed in a report to be issued by the Keystone Center in the next few months, FDA Office of Special Nutritionals Director Elizabeth Yetley, PhD, told the first meeting of the President's Commission on Dietary Supplement Labels on Feb. 16. The report will reflect a series of meetings that have taken place among the federal government, industry and academia on the Nutrition Labeling & Education Act.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084824

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel